A test of breast cancer tumors can reliably identify those that are less aggressive and susceptible to hormone-based drug therapy, researchers find. It could allow many women and their doctors the option of skipping chemotherapy, they say.
A test of breast cancer tumors can reliably identify those that are less aggressive and susceptible to hormone-based drug therapy, researchers find. It could allow many women and their doctors the option of skipping chemotherapy, they say.